정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1836 | Active, not recruiting | COVID-19 Anosmia Study | Covid19 | Drug: Omega-3 Fatty Acid Supplement Drug: Placebo/Control |
Phase 2 | Icahn School of Medicine at Mount Sinai | OTHER | 126 | All | 18 Years | Mount Sinai Hospital, New York, New York, United States |
| 1835 | Completed | COVID-19 Antibody Plasma Research Study in Hospitalized Patients | COVID-19 | Biological: High-titer Convalescent COVID-19 Plasma (CCP1) Biological: Standard-titer Convalescent COVID-19 plasma (CCP2) |
Phase 2 | University of North Carolina, Chapel Hill | OTHER | 56 | All | 18 Years ~ 99 Years | University of North Carolina Health Care, Chapel Hill, North Carolina, United States |
| 1834 | Completed | COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial | COVID-19 | Drug: Enoxaparin Prefilled Syringe [Lovenox] | Phase 2 | Johns Hopkins All Children's Hospital | OTHER | 40 | All | ~ 18 Years | Children's of Alabama, Birmingham, Alabama, United States Children's Hospital Los Angeles, Los Angeles, California, United States Hemostasis and Thrombosis Center UC Davis, Sacramento, California, United States Rady Children's Hospital, San Diego, California, United States Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States Children's Hospital of Atlanta, Atlanta, Georgia, United States Lurie Children's Hospital, Chicago, Illinois, United States Rush University Medical Center, Chicago, Illinois, United States Children's Hospital New Orleans, New Orleans, Louisiana, United States Johns Hopkins Hospital and Children's Center, Baltimore, Maryland, United States Boston Children's Hospital, Boston, Massachusetts, United States Children's Hospital of Michigan, Detroit, Michigan, United States Cohen Children's Medical Center, New Hyde Park, New York, United States Akron Children's Hospital, Akron, Ohio, United States Children's Hospital Pittsburgh, Pittsburgh, Pennsylvania, United States Children's Medical Center of Dallas, Dallas, Texas, United States |
| 1833 | Recruiting | COVID-19 Antithrombotic Rivaroxaban Evaluation | COVID-19 | Drug: Rivaroxaban 10 mg | Phase 4 | Hospital Alemao Oswaldo Cruz, Bayer, Hospital Israelita Albert Einstein, Hospital do Coracao, Hospital Sirio-Libanes, Hospital Moinhos de Vento, Brazilian Research In Intensive Care Network, Brazilian Clinical Research Institute | OTHER | 1000 | All | 18 Years | Clinica Senhor do Bonfim, Feira de Santana, Bahia, Brazil Hospital Maternidade Sao Vicente de Paulo, Barbalha, Ceara, Brazil Hospital de Base do Distrito Federal, Brasilia, Distrito Federal, Brazil Hospital de Campanha Covid-19 Goiania/Sesgo, Goiania, Goias, Brazil Hospital Estadual de Urgencias de Trindade/SESGO, Trindade, Goias, Brazil Nucleo de Pesquisa Clinica do Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil Hospital Sao Lucas, Belo Horizonte, Minas Gerais, Brazil Santa Casa de Misericordia de Passos, Passos, Minas Gerais, Brazil Hospital Universitario Regional de Maringa, Maringa, Parana, Brazil Beneficencia Nipo Brasileira Da Amazonia, Belem, Para, Brazil Hospital Adventista de Belem, Belem, Para, Brazil Associacao Dr. Bartholomeu Tacchini, Bento Goncalves, Rio Grande Do Sul, Brazil Hospital Sao Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil Hospital das Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil Hospital Universitario de Santa Maria, Santa Maria, Rio Grande Do Sul, Brazil Clinica Procardio Ltda, Blumenau, Santa Catarina, Brazil H&W Cardiologia LTDA, Joinville, Santa Catarina, Brazil Irmandade santa Casa de Araras, Araras, Sao Paulo, Brazil Alphacor Cardiologia Clinica e Diagnostica LTDA, Barueri, Sao Paulo, Brazil Maestri e Kormann Consultoria Medico-Cientifica LTDA - EPP, Blumenau, Sao Paulo, Brazil Hospital Regional do Litoral Norte - Instituto Socrates Guanaes, Caraguatatuba, Sao Paulo, Brazil Hospital Santos Dumont Litoral Norte, Caraguatatuba, Sao Paulo, Brazil Hospital de Corderiopolis, Cordeiropolis, Sao Paulo, Brazil Hospital Regional Jorge Rossman - Instituto Socrates Guanaes, Itanhaem, Sao Paulo, Brazil Hospital Carlos Fernando Malzoni, Matao, Sao Paulo, Brazil Hospital Moinhos de Vento, Porto Alegre, Sao Paulo, Brazil Hospital Regional de Registro - Instituto Socrates Guanaes, Registro, Sao Paulo, Brazil Hospital Unimed Ribeirao Preto, Ribeirao Preto, Sao Paulo, Brazil Kaiser Clinica e Hospital Dia, Sao Jose do Rio Preto, Sao Paulo, Brazil Braile Hospital Dia Ltda, Sao Jose Do Rio Preto, Sao Paulo, Brazil Hospital Policlin, Sao Jose Dos Campos, Sao Paulo, Brazil Hospital Regional de Sao Jose dos Campos - Instituto Socrates Guanaes, Sao Jose Dos Campos, Sao Paulo, Brazil Santa Casa de Misericordia de Votuporanga, Votuporanga, Sao Paulo, Brazil International Research Center - Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil Hospital Leforte Liberdade, Sao Paulo, Brazil Incor - Instituto do Coracao do Hospital das Clinicas da FMUSP, Sao Paulo, Brazil |
| 1832 | Recruiting | Covid-19 Associated Coagulopathy | COVID 19 Associated Coagulopathy | Drug: Intermediate dose thromboprophylaxis Drug: Standard of Care thromboprophylaxis |
Phase 4 | University of Iowa | OTHER | 170 | All | 18 Years ~ 100 Years | University of Iowa, Iowa City, Iowa, United States Gundersen Health System, La Crosse, Wisconsin, United States |
| 1831 | Not yet recruiting | COVID-19 Booster Vaccination in Persons With Multiple Sclerosis | PWMS Who Have Completed Vaccination Against COVID-19 and Test Negative for COVID-19 Spike Protein Antibodies Using a Commercial Assay | Biological: Homologous booster Biological: Heterologous booster |
Not Applicable | Griffin Hospital, Yale-Griffin Prevention Research Center | OTHER | 60 | All | 18 Years | |
| 1830 | Recruiting | COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders | Systemic Sclerosis (SSc) | Biological: Moderna mRNA-1273 Biological: BNT162b2 Biological: Ad26.COV2.S Drug: IS (MMF or MPA) Drug: IS (MTX) Biological: IS (B cell depletion therapy) |
Phase 2 | National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc. | NIH | 600 | All | 18 Years | UCLA Medical Center: Division of Rheumatology, Los Angeles, California, United States Yale University School of Medicine: Rheumatology, Allergy & Immunology, New Haven, Connecticut, United States The Emory Clinic: Division of Rheumatology, Atlanta, Georgia, United States Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases, Boston, Massachusetts, United States Brigham & Women's Hospital: Department of Medicine, Rheumatology, Immunology, Boston, Massachusetts, United States University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology, Ann Arbor, Michigan, United States Washington University School of Medicine in St. Louis: Division of Rheumatology, Saint Louis, Missouri, United States Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset, New York, United States New York University Langone Medical Center: Department of Medicine, Division of Rheumatology, New York, New York, United States Columbia University Irving Medical Center: Department of Neurology, Multiple Sclerosis Center, New York, New York, United States Duke University Medical Center: Division of Rheumatology and Immunology, Durham, North Carolina, United States Cleveland Clinic, Cleveland, Ohio, United States Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program, Oklahoma City, Oklahoma, United States Temple Health: Rheumatology, Philadelphia, Pennsylvania, United States University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States Medical University of South Carolina, Nexus Research Center, Charleston, South Carolina, United States University of Texas Houston Medical School: Division of Rheumatology and Clinical Immunogenetics, Houston, Texas, United States Benaroya Research Institute at Virginia Mason: Internal Medicine, Seattle, Washington, United States |
